Marshall Dahl, MD, PhD

Clinical Professor
Head, Division of Endocrinology
Education
University of British Columbia, 1986, MD
University of British Columbia, 1991, Internal Medicine Residency
University of British Columbia, 1992, Endocrinology Fellowship
University of British Columbia, 1982, PhD (Physiology)
Clinical Interests
Adrenal, Calcium, Diabetes, Male Hypogonadism/ Low Testosterone, Menstrual Disorders/Ovarian Dysfunction, Osteoporosis, Pituitary, Thyroid, Transgender Health
Research Interests
Transgender Health
Publications

See Dr. Dahl’s publications here

1. Harris D, Barts A, Connors J, Dahl M, Elliott T, Kong J, Keane T, Thompson D, Stafford S, Ur E, Sirrs S. Glucocorticoid-induced hyperglycemia is prevalent and unpredictable for patients undergoing cancer therapy: an observational cohort study. Curr Oncol. 2013 Dec;20(6):e532-8.

2. Cameron, C, Virani A Dean H, Evans M,Dolovich L, Dahl M Utilization and Expenditure on Blood Glucose Test Strips in Canada. Canadian Journal of Diabetes. 2010; 34 (1):34-40.

3. McIntosh B, Yu C, Lal A, Chelak K, Cameron C, Singh S, Dahl M  Efficacy of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin: a systematic review and meta-analysis.  Open Medicine 2010;4(2):e102.

4. Dahl M, Feldman J, Goldberg JM, Jaberi A Physical Aspects of Transgender Endocrine Therapy. International Journal of Transgenderism  2006; Vol 9 Issue: ¾, p111-134.

Contact
Gordon and Leslie Diamond Centre Room 4145
2775 Laurel St.
Vancouver, BC V5Z 1M9
Canada
phone: 604–875–5577
fax: 604–875–5188

Read More | No Comments